Annovis Bio Files Proxy Statement for Shareholder Meeting
Ticker: ANVS · Form: DEFA14A · Filed: May 1, 2025 · CIK: 1477845
| Field | Detail |
|---|---|
| Company | Annovis Bio, Inc. (ANVS) |
| Form Type | DEFA14A |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, shareholder-meeting
Related Tickers: ANVS
TL;DR
Annovis Bio (ANVS) proxy statement out - vote your shares!
AI Summary
Annovis Bio, Inc. filed a Definitive Proxy Statement (DEFA14A) on May 1, 2025, for its annual shareholder meeting. The filing outlines the proposals to be voted on by shareholders, including the election of directors and the ratification of the appointment of its independent registered public accounting firm. The company is seeking shareholder approval for routine corporate governance matters.
Why It Matters
This filing is crucial for shareholders to understand the agenda and proposals for the upcoming annual meeting, allowing them to exercise their voting rights on company leadership and governance.
Risk Assessment
Risk Level: low — This is a routine proxy statement detailing upcoming shareholder votes and does not contain new financial or strategic information that would inherently increase risk.
Key Players & Entities
- Annovis Bio, Inc. (company) — Registrant filing the proxy statement
- QR Pharma, Inc. (company) — Former company name of Annovis Bio, Inc.
FAQ
What is the purpose of this DEFA14A filing?
The purpose of this DEFA14A filing is to provide shareholders with the official proxy statement for Annovis Bio, Inc.'s annual shareholder meeting, detailing the proposals to be voted upon.
When was this filing made with the SEC?
This filing was made with the SEC on May 1, 2025.
What is the company's Central Index Key (CIK)?
Annovis Bio, Inc.'s Central Index Key (CIK) is 0001477845.
What is the company's business address?
The company's business address is 101 Lindenwood Drive, Suite 225, Malvern, PA 19355.
What was the former name of Annovis Bio, Inc. and when did the name change occur?
The former name of Annovis Bio, Inc. was QR Pharma, Inc., and the date of the name change was December 2, 2009.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 1, 2025 regarding Annovis Bio, Inc. (ANVS).